Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigenic responses in reactive arthritis.

G Kingsley1, G Panayi

  • 1Guy's Hospital, University of London, England.

Rheumatic Diseases Clinics of North America
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life.

Seminars in arthritis and rheumatism·2019
Same author

Infliximab improves vascular stiffness in patients with rheumatoid arthritis.

Annals of the rheumatic diseases·2008
Same author

Management of septic arthritis: a systematic review.

Postgraduate medical journal·2008
Same author

Management of septic arthritis: a systematic review.

Annals of the rheumatic diseases·2007
Same author

BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults.

Rheumatology (Oxford, England)·2006
Same author

Adalimumab-induced asthma.

Rheumatology (Oxford, England)·2005

Reactive arthritis (ReA) synovitis is driven by specific T-cell responses to bacterial fragments in the joint, with nonspecific T cells amplifying inflammation. This research clarifies the immune mechanisms underlying ReA and its association with HLA-B27.

Area of Science:

  • Immunology
  • Rheumatology
  • Microbiology

Background:

  • Reactive arthritis (ReA) is a form of inflammatory arthritis that can occur after a distant infection.
  • The association between ReA and the human leukocyte antigen HLA-B27 is well-established but not fully understood.
  • Current understanding of ReA pathogenesis involves both specific immune responses to microbial triggers and host genetic factors.

Purpose of the Study:

  • To elucidate the mechanisms of ReA pathogenesis, focusing on the role of specific immune responses to bacterial antigens in the synovium.
  • To investigate the contribution of T-cell and B-cell responses in the development and amplification of ReA synovitis.
  • To explore the potential role of HLA-B27 in presenting arthritogenic peptides and its association with ReA.

Main Methods:

Related Experiment Videos

  • Analysis of bacterial antigens within ReA synovium.
  • Review of humoral immune responses, including antibody synthesis and specificity.
  • Examination of cellular immune responses, specifically synovial mononuclear cell (MNC) proliferation to bacterial fragments.
  • Characterization of T-cell subsets (CD4+, CD8+) involved in the proliferative response.
  • Assessment of antigen-independent recruitment of nonspecific T cells.

Main Results:

  • Bacterial antigens, in a nonviable form, are present in ReA synovium and stimulate specific T-cell responses.
  • Intrasynovial bacteria-specific antibody synthesis and maturation suggest persistent antigen stimulation.
  • A specific synovial MNC proliferative response to bacterial fragments, mediated by CD4+ and CD8+ T cells restricted by MHC class I and II, was identified.
  • Antigen-independent recruitment of nonspecific T cells contributes to synovitis amplification.
  • The humoral immune response may be absent in some ReA patients, indicating a secondary role for antibodies.

Conclusions:

  • ReA synovitis is primarily driven by specific T-cell proliferation to bacterial fragments within the joint.
  • Nonspecific T cells amplify the inflammatory process, while antibodies play a secondary role.
  • Further research into HLA-B27 and arthritogenic peptide presentation is needed to fully understand ReA pathogenesis.
  • Advances in understanding these mechanisms may lead to targeted immunotherapies or vaccines for ReA.